HOME >> MEDICINE >> NEWS
Reduced greenhouse gas emissions required to avoid dangerous increases in heat stress

WEST LAFAYETTE, Ind. -- A study led by a Purdue University researcher projects a 200 percent to 500 percent increase in the number of dangerously hot days in the Mediterranean by the end of the 21st century if the current rate of greenhouse gas emissions continues. The study found France would be subjected to the largest projected increase of high-temperature extremes.

The study also showed a reduction in greenhouse gas emissions could reduce the intensification of dangerously hot days projected in the scenario by up to 50 percent.

"Rare events today, like the 2003 heat wave in Europe, will become much more common as greenhouse gas concentrations increase," said Noah Diffenbaugh, the Purdue assistant professor of earth and atmospheric sciences who led the study. "The frequency at which that scale of event occurs at high greenhouse gas concentrations is staggering. Rare events become the norm, and the extreme events of the future are unprecedented in their severity."

A 2003 heat wave led to 15,000 deaths in France and almost 3,000 in Italy. The researchers found that global warming causes summer temperatures to dramatically exceed the range that was correlated with the increased number of deaths.

"The thresholds of the 2003 event are substantially exceeded in the future in both of our research scenarios," said Diffenbaugh, who is a member of Purdue's Climate Change Research Center. "This research is about understanding the response to different emissions levels. We find that decreases in greenhouse gas emissions greatly reduce the impact, but we see negative effects even with reduced emissions. Technological and behavioral changes that are made now will have a big influence on what actually happens in the future."

In addition to the human health risks, extremely high temperatures could impact the economy of this region, which includes metropolitan areas such as Rome, Paris and Barcelona, said Jeremy Pal, co-researc
'"/>

Contact: Elizabeth K. Gardner
ekgardner@purdue.edu
765-494-2081
Purdue University
14-Jun-2007


Page: 1 2 3 4

Related medicine news :

1. Reduced dietary fat intake may decrease breast cancer recurrence
2. Reduced antibiotic prescribing is associated with increased hospital admissions
3. Reduced insulin in the brain triggers Alzheimers degeneration
4. Reduced brain volume may predict dementia in healthy elderly people
5. First greenhouse gas animations produced using Envisat SCIAMACHY data
6. Transcontinental wildfire emissions monitored from space
7. Cell phone emissions excite the brain cortex
8. Breast-cancer risk linked to exposure to traffic emissions at menarche, first birth
9. Penn study finds pro-death proteins required to regulate healthy immune function
10. OCT1 required for therapeutic effects of diabetes drug Metformin
11. Malignant melanoma cells secrete protein required for embryo formation

Post Your Comments:
(Date:6/18/2013)... Alabama (PRWEB) June 19, 2013 Consumer ... and two other law firms have launched a new ... injuries caused by dialysis. The website is http://www.DialysisLawsuitAttorneys.com ... was time to begin offering legal services to people ... drugs GranuFlo and NaturaLyte, or who may have suffered ...
(Date:6/18/2013)... 19, 2013 oBand Surgery Centers, a ... holding complimentary weight loss seminars in Los Angeles this ... be accessed at their official website. oBand Surgery Centers ... time. Their highly skilled panel of surgeons and dedicated ... , A senior executive working with oBand Surgery Centers ...
(Date:6/18/2013)... As a sponsor of the 2013 Fourth of July ... Lake Meridian Chiropractic want you to get out and celebrate! ... event and are excited to be involved. “My husband and I ... loved going to the Kent Splash event. It's a tradition that ... to financially support this fun day.” , The 2013 ...
(Date:6/18/2013)... IL (PRWEB) June 18, 2013 Exposed Skin ... helping thousands of acne suffers of all ages finally achieve ... other acne treatment products, this new acne clearing system combines ... acne, and prevent new acne from forming. , ... ExposedSkinCareReview.org believes these products are some of the most effective ...
(Date:6/18/2013)... (PRWEB) June 19, 2013 "What if ... a day could boost your health and well-being? Well, ... founder of Sublime Beauty®. "It is called Skin ... centuries but became a lost art. Now, people are ... about Skin Brushing, and so do certain health conscious ...
Breaking Medicine News(10 mins):Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 2Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 3Health News:Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama 4Health News:oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June 2Health News:Lake Meridian Chiropractic of Kent, WA to Sponsor the Fireworks Finale at 15th Annual Fourth of July Splash 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3Health News:The Easiest Way to Contribute to Better Health and Well-Being Starting Today and for Under $20, Says Sublime Beauty® 2
(Date:6/18/2013)... -- , Safinamide significantly improves responder ... add-on to levodopa Safinamide is associated ... fluctuating PD patients as add-on to levodopa ... a research and development company focused on novel ... S.p.A., a pharmaceutical company strongly committed to the ...
(Date:6/18/2013)... 18, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... announced today that VPII Escrow Corp., a newly formed ... its offer of approximately $3.2 billion aggregate principal amount ... be due in 2021 and in 2023, with final ... to use the net proceeds from the offering, together ...
(Date:6/18/2013)... June 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... on the development and commercialization of novel bile acid ... pricing of an underwritten public offering of 1,730,000 shares ... of $33.01 per share.  In addition, Intercept has granted ... an additional 259,500 shares of common stock. ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
Cached News: